Back to search results

Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Glioblastoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Tanner M Johanns, MD, PhD) · tannerjohanns@wustl.edu · 314-362-9355
    Contact: Principal Investigator (Tanner M Johanns, MD, PhD)
    Jingqin R Luo, PhD (Sub-investigator)
    Myung Sik Jeon (Sub-investigator)
    Milan Chheda, MD (Sub-investigator)
    Omar Butt, MD, PhD (Sub-investigator)
    Julie Schutte, MSN, AFRN, FNP-C (Sub-investigator)
Study leads

  • Tanner M Johanns, MD, PhD

    Principal Investigator

    Washington University School of Medicine

View source on ClinicalTrials.gov(opens in a new tab)